NAT10 and hepatocellular carcinoma: Treatment with panobinostat markedly suppressed HCC cell lung metastasis and NAT10 expression in vivo, highlighting that it is an effective and safe lead compound that targets NAT10-mediated ac4C for potential HCC therapy [20].